To elucidate if HAVCR2 mutations are only limited in SPTCL patients or if there is heterogenicity in various lymphoma types, we explored the change and significance of HAVCR2 mutations in T-cell or B-cell lymphoma. The gene discussed is HAVCR2; the disease is lymphoma.